Literature DB >> 29607296

Timing of Anticoagulation for Portal Vein Thrombosis in Liver Cirrhosis: A US Hepatologist's Perspective.

Patrick G Northup1, Jessica P E Davis1.   

Abstract

Entities:  

Year:  2018        PMID: 29607296      PMCID: PMC5874479          DOI: 10.2478/jtim-2018-0001

Source DB:  PubMed          Journal:  J Transl Int Med        ISSN: 2224-4018


× No keyword cloud information.
  18 in total

1.  Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.

Authors:  M A Yerdel; B Gunson; D Mirza; K Karayalçin; S Olliff; J Buckels; D Mayer; P McMaster; J Pirenne
Journal:  Transplantation       Date:  2000-05-15       Impact factor: 4.939

2.  Portal vein thrombosis and survival in patients with cirrhosis.

Authors:  Michael J Englesbe; James Kubus; Wajee Muhammad; Christopher J Sonnenday; Theodore Welling; Jeffrey D Punch; Raymond J Lynch; Jorge A Marrero; Shawn J Pelletier
Journal:  Liver Transpl       Date:  2010-01       Impact factor: 5.799

3.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.

Authors:  Guadalupe Garcia-Tsao; Juan G Abraldes; Annalisa Berzigotti; Jaime Bosch
Journal:  Hepatology       Date:  2016-12-01       Impact factor: 17.425

4.  Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.

Authors:  Filipe Nery; Sylvie Chevret; Bertrand Condat; Emmanuelle de Raucourt; Larbi Boudaoud; Pierre-Emmanuel Rautou; Aurelie Plessier; Dominique Roulot; Cendrine Chaffaut; Valerie Bourcier; Jean-Claude Trinchet; Dominique-Charles Valla
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

Review 5.  Portal Vein Recanalization and Transjugular Intrahepatic Portosystemic Shunt Creation for Chronic Portal Vein Thrombosis: Technical Considerations.

Authors:  Bartley Thornburg; Kush Desai; Ryan Hickey; Laura Kulik; Daniel Ganger; Talia Baker; Michael Abecassis; Robert J Lewandowski; Riad Salem
Journal:  Tech Vasc Interv Radiol       Date:  2016-02-06

6.  Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis.

Authors:  Shiv K Sarin; Cyriac A Philips; Patrick S Kamath; Ashok Choudhury; Hitoshi Maruyama; Filipe G Nery; Dominique C Valla
Journal:  Gastroenterology       Date:  2016-08-27       Impact factor: 22.682

7.  Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation.

Authors:  C Francoz; J Belghiti; V Vilgrain; D Sommacale; V Paradis; B Condat; M H Denninger; A Sauvanet; D Valla; F Durand
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

8.  Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.

Authors:  N M Intagliata; Z H Henry; H Maitland; N L Shah; C K Argo; P G Northup; S H Caldwell
Journal:  Dig Dis Sci       Date:  2016-01-02       Impact factor: 3.199

9.  Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients.

Authors:  Jonathan G Stine; Shawn J Pelletier; Timothy M Schmitt; Robert J Porte; Patrick G Northup
Journal:  HPB (Oxford)       Date:  2015-12-10       Impact factor: 3.647

10.  Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.

Authors:  Andrea De Gottardi; Jonel Trebicka; Christoph Klinger; Aurélie Plessier; Susana Seijo; Benedetta Terziroli; Lorenzo Magenta; David Semela; Elisabetta Buscarini; Philippe Langlet; Jan Görtzen; Angela Puente; Beat Müllhaupt; Carmen Navascuès; Filipe Nery; Pierre Deltenre; Fanny Turon; Cornelius Engelmann; Rupen Arya; Karel Caca; Markus Peck-Radosavljevic; Frank W G Leebeek; Dominique Valla; Juan Carlos Garcia-Pagan
Journal:  Liver Int       Date:  2016-11-19       Impact factor: 5.828

View more
  1 in total

1.  Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus.

Authors:  Ellen G Driever; Fien A von Meijenfeldt; Jelle Adelmeijer; Robbert J de Haas; Marius C van den Heuvel; Chandrasekaran Nagasami; John W Weisel; Constantino Fondevila; Robert J Porte; Anabel Blasi; Nigel Heaton; Stephen Gregory; Pauline Kane; William Bernal; Yoh Zen; Ton Lisman
Journal:  Hepatology       Date:  2021-12-05       Impact factor: 17.298

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.